1. Home
  2. CGEM vs CCB Comparison

CGEM vs CCB Comparison

Compare CGEM & CCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CGEM
  • CCB
  • Stock Information
  • Founded
  • CGEM 2016
  • CCB 1997
  • Country
  • CGEM United States
  • CCB United States
  • Employees
  • CGEM N/A
  • CCB N/A
  • Industry
  • CGEM Biotechnology: Pharmaceutical Preparations
  • CCB Major Banks
  • Sector
  • CGEM Health Care
  • CCB Finance
  • Exchange
  • CGEM Nasdaq
  • CCB Nasdaq
  • Market Cap
  • CGEM 530.0M
  • CCB 1.3B
  • IPO Year
  • CGEM 2021
  • CCB 2018
  • Fundamental
  • Price
  • CGEM $7.82
  • CCB $102.62
  • Analyst Decision
  • CGEM Strong Buy
  • CCB Strong Buy
  • Analyst Count
  • CGEM 5
  • CCB 3
  • Target Price
  • CGEM $30.00
  • CCB $103.33
  • AVG Volume (30 Days)
  • CGEM 367.2K
  • CCB 136.9K
  • Earning Date
  • CGEM 08-07-2025
  • CCB 07-28-2025
  • Dividend Yield
  • CGEM N/A
  • CCB N/A
  • EPS Growth
  • CGEM N/A
  • CCB 17.53
  • EPS
  • CGEM N/A
  • CCB 3.36
  • Revenue
  • CGEM N/A
  • CCB $322,160,000.00
  • Revenue This Year
  • CGEM N/A
  • CCB $109.11
  • Revenue Next Year
  • CGEM N/A
  • CCB $36.30
  • P/E Ratio
  • CGEM N/A
  • CCB $30.53
  • Revenue Growth
  • CGEM N/A
  • CCB 25.44
  • 52 Week Low
  • CGEM $6.85
  • CCB $43.43
  • 52 Week High
  • CGEM $21.01
  • CCB $106.38
  • Technical
  • Relative Strength Index (RSI)
  • CGEM 44.54
  • CCB 69.56
  • Support Level
  • CGEM $7.26
  • CCB $95.68
  • Resistance Level
  • CGEM $8.05
  • CCB $94.09
  • Average True Range (ATR)
  • CGEM 0.44
  • CCB 3.63
  • MACD
  • CGEM -0.07
  • CCB 1.52
  • Stochastic Oscillator
  • CGEM 32.55
  • CCB 85.19

About CGEM Cullinan Oncology Inc.

Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, creates differentiated ideas, identifies the appropriate targets, and selects the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications. It has one reporting and one operating segment, which is the business of developing immunology and oncology therapies.

About CCB Coastal Financial Corporation

Coastal Financial Corp is a financial service provider. The company provides banking products and services to consumers and small to medium-sized businesses. Its business is conducted through three reportable segments: The community bank, CCBX, and treasury & administration. The primary focus of the community bank is on providing a wide range of banking products and services to consumers and small to medium-sized businesses in the broader Puget Sound region in the state of Washington and through the Internet and mobile banking applications.

Share on Social Networks: